Skip to main content
logo
Ashland Inc. (ASH)
NYSE: ASH · Real-Time Price · USD
70.91
+0.21 (0.30%)
At close: Sep 11, 2026, 4:00 PM EDT
71.99
+1.08 (1.52%)
After-hours: Sep 11, 2026, 7:53 PM EDT

Revenue

Millions USD. Fiscal year is Oct - Sep.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20
Life Sciences Revenue
180.00M
Personal Care Revenue
155.00M
Specialty Additives Revenue
136.00M
Intermediates Revenue
37.00M
Eliminations from Revenue
-11.00M
Revenue (Total)
497.00M

EBIT

Millions USD. Fiscal year is Oct - Sep.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20
Life Sciences Operating Income
45.00M
Personal Care Operating Income
29.00M
Specialty Additives Operating Income
3.00M
Intermediates Operating Income
3.00M
Unallocated and Other Operating Income
-37.00M
Operating Income (Total)
43.00M

EBITDA

Millions USD. Fiscal year is Oct - Sep.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20
Life Sciences EBITDA
60.00M
Personal Care EBITDA
44.00M
Specialty Additives EBITDA
18.00M
Intermediates EBITDA
4.00M
Unallocated and Other EBITDA
-36.00M
Operating Income (Total)
43.00M

Key Performance Indicators

Millions USD. Fiscal year is Oct - Sep.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20
Change in Sales Due to Volume
28.00M
Change in Sales Due to Product Pricing/Mix
3.00M